Back
Dainichiseika Color & Chemicals Mfg. Co., Ltd. 10K Form
Buy
97
DCHCF
Dainichiseika Color & Chemicals Mfg. Co., Ltd.
Last Price:
$12.11
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DCHCF News And Ratings
See the #1 stock for the next 7 days that we like better than DCHCF
DCHCF Financial Statistics
Sales & Book Value
| Annual Sales: | $818.4M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $48.95 |
| Price / Book: | 0.99 |
Profitability
| EPS (TTM): | 2.67850 |
|---|---|
| Net Income (TTM): | $47.1M |
| Gross Margin: | $165.4M |
| Return on Equity: | 5.45% |
| Return on Assets: | 3.6% |
Dainichiseika Color & Chemicals Mfg. Co., Ltd. Earnings Forecast
Key Dainichiseika Color & Chemicals Mfg. Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 43 years for DCHCF is 20.22%.
-
The Selling, General & Administrative Expenses for DCHCF have been equal to 14.60% of Gross Profit Margin.
-
The Research & Development expenses have been 2.39% of Revenue.
-
The Interest Expense is 2.36% of Operating Income.
-
The Net Earning history of DCHCF is 8.41% of Total Revenues.
-
Per Share Earnings over the last 43 years have been positive in 22 years.
Dainichiseika Color & Chemicals Mfg. Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | DCHCF |
| Website: | daicolor.co.jp |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 2.34 |
| Quick Ratio: | 1.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.32 |
|---|---|
| Forward P/E Ratio: | 0 |
DCHCF Technical Analysis vs Fundamental Analysis
Buy
97
Dainichiseika Color & Chemicals Mfg. Co., Ltd. (DCHCF)
is a Buy
Is Dainichiseika Color & Chemicals Mfg. Co., Ltd. a Buy or a Sell?
-
Dainichiseika Color & Chemicals Mfg. Co., Ltd. stock is rated a BuyThe current Dainichiseika Color & Chemicals Mfg. Co., Ltd. [DCHCF] share price is $12.11. The Score for DCHCF is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.